DDMAC warning and untitled letters in 2008 total 21

Share this article:

The FDA's Division of Drug Marketing, Advertising and Communications issued 21 warning and untitled letters in 2008 – scarcely more than the 20 letters the unit sent out in 2007.

As in 2007, 10 were “warning letters,” the remainder being of the somewhat less serious “untitled” variety.

In 2006, DDMAC issued 22 letters reprimanding drug manufacturers for promotional materials deemed violative of the Food, Drug and Cosmetics Act, typically for overstating efficacy and/or underplaying risks, but 14 of those were warning letters.

Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZeneca beefs up respiratory portfolio

AstraZeneca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.